EGFR and adenocarcinoma: Based on IC50 values (EGFR dimerization inhibition), the compound DSF-102 was selected for further biological evaluations on adenocarcinoma A549 cell line that is known to overexpress EGFR and to show KRAS mutations in codon 12 [21].